2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Hepatocellular
147
Carcinoma, Renal Cell
37
Parkinson Disease 4, Autosomal Dominant Lewy Body
31
Neoplasms
28
Cholangiocarcinoma
26
Endometrial Neoplasms
19
Thyroid Neoplasms
17
Liver Neoplasms
17
Melanoma
15
Stomach Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Biliary Tract Neoplasms
13
Recurrence
9
Neoplasm Metastasis
9
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Breast Neoplasms
8
Uterine Cervical Neoplasms
7
Triple Negative Breast Neoplasms
5
Thyroid Carcinoma, Anaplastic
5
Small Cell Lung Carcinoma
5
Neuroendocrine Tumors
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Pancreatic Neoplasms
4
Kidney Neoplasms
4
Carcinoma, Transitional Cell
4
Carcinoma
4
Adenocarcinoma
4
Thyroid Cancer, Papillary
3
Interventions
Surveys and Questionnaires
2
oncomodulin
1
lenvatinib
1
Sex
1
Proctectomy
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Gastrectomy
1
Focus Groups
1
Exercise Test
1
Blood Specimen Collection
1
Aging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Coitus
×
lenvatinib
×
Clear all
NCT05789667
2024-12-06
Gisel
Regina Elena Cancer Institute
Recruiting
50 enrolled